For a menopausal woman undergoing hormone therapy, breast cancer risk is significantly influenced by the specific combination of hormones she receives.

That’s according to Oxford University scientists who recently conducted an extensive analysis of previous studies on the topic. Duration of therapy also plays a role, with risk rising substantially after the five-year mark.